Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 2

Association of Macrophage Migration Inhibitory FactorGene - 173 G/C Polymorphism with Occurrence andSeverity of Acute Pancreatitis

Pages
182–187
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, considering the severity of AP, the statistical significance could not be proven.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Promoter polymorphism -173G/C of macrophage migration inhibitory factor (MIF) is related to higher MIF levels.
📊
Key Findings & Data:In this study, we have investigated the effects of this polymorphism with the occurrence and severity of acute pancreatitis (AP).Methods: Sixty-two AP patients and 83 healthy volunteers were included in our study.
💡
Conclusion & Impact:However, considering the severity of AP, the statistical significance could not be proven.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Promoter polymorphism -173G/C of macrophage migration inhibitory factor (MIF) is related to higher MIF levels. In this study, we have investigated the effects of this polymorphism with the occurrence and severity of acute pancreatitis (AP).Methods: Sixty-two AP patients and 83 healthy volunteers were included in our study. The demographical, clinical, labora-tory and radiological findings were recorded, and peripheral blood samples were genetically analyzed.Results: In this study, 35 female and 27 male patients were included. The mean age was 51. The AP severity was mild at 37 patients, moderate at 21 and severe at four patients. Genotype and allelic distribution at patient and control groups were statistically different (p<0.001; p=0.03). Although no significant difference between mild, moderate and severe AP groups detected, there was a tendency of CC genotype and C allele frequency being higher at moderate and severe AP and GG genotype being higher at mild AP. Eight of nine SIRS developed patients had CC genotype and C allele frequency was 88.9%. The leucocyte count at CC genotype and at C allele increased.Discussion and Conclusion: According to our results, CC genotype and C allele frequency were related with AP occurrence. However, considering the severity of AP, the statistical significance could not be proven.

🔖

Cite This Article

UZUN, M. A., KAYAOĞLU, S. A., TİLKİ, M., OCAK, S. B., EREN, P. A., DOĞAN, T. (2020). Association of Macrophage Migration Inhibitory FactorGene - 173 G/C Polymorphism with Occurrence andSeverity of Acute Pancreatitis. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 2, 182–187. https://ajindex.com/articles/216783

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the At-lanta classification and definitions by international consen-sus. Gut 2013;62:102–11
  2. Choi JH, Kim MH, Cho DH, Oh D, Lee HW, Song TJ, et al. Revised Atlanta classification and determinant-based classification: Which one better at stratifying outcomes of patients with acute pancreatitis? Pancreatology 2017;17:194–200
  3. Pongprasobchai S, Vibhatavata P, Apisarnthanarak P. Severity, Treatment, and Outcome of Acute Pancreatitis in Thailand: The First Comprehensive Review Using Revised Atlanta Classi-fication. Gastroenterol Res Pract 2017;2017:3525349
  4. Guo Q, Li M, Chen Y, Hu W. Determinant-based classification and revision of the Atlanta classification, which one should we choose to categorize acute pancreatitis? Pancreatology 2015;15:331–6
  5. Acevedo-Piedra NG, Moya-Hoyo N, Rey-Riveiro M, Gil S, Sempere L, Martínez J, et al. Validation of the determinant-based classification and revision of the Atlanta classification systems for acute pancreatitis. Clin Gastroenterol Hepatol 2014;12:311–6
  6. Kadiyala V, Suleiman SL, McNabb-Baltar J, Wu BU, Banks PA, Singh VK. The Atlanta Classification, Revised Atlanta Classifi-cation, and Determinant-Based Classification of Acute Pan-creatitis: Which Is Best at Stratifying Outcomes? Pancreas 2016;45:510–5
  7. Deng LH, Hu C, Cai WH, Chen WW, Zhang XX, Shi N, et al. Plasma cytokines can help to identify the development of severe acute pancreatitis on admission. Medicine (Baltimore) 2017;96:e7312
  8. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreati-tis. J Hepatobiliary Pancreat Surg 2002;9:401–10
  9. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, et al. Pathophysiology of acute pancreatitis. Pancreatology 2005;5:132–44
  10. Dambrauskas Z, Giese N, Gulbinas A, Giese T, Berberat PO, Pundzius J, et al. Different profiles of cytokine expression dur-ing mild and severe acute pancreatitis. World J Gastroenterol 2010;16:1845–53
  11. Bloom BR, Bennett B. Mechanism of a reaction in vitro associ-ated with delayed-type hypersensitivity. Science 1966;153:80–2
  12. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage mi-gration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 2010;23:257–64
  13. Cho YD, Choi SH, Kim JY, Park SJ, Yoon YH, Cho HJ, et al. Macrophage migration inhibitory factor levels correlate with an